1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
| {
| "batch_id": "BATCH-STOCK-VALUATION-QINGFENGPU-TIMELINE-20260825-001",
| "ticker": "002317.SZ",
| "company": "众生药业",
| "as_of": "2026-08-25",
| "v2_status": "BLOCKED",
| "v2_failure": {
| "complete": false,
| "error": "ValueError: E_HISTORICAL_SHARES_UNPROVEN：quote f124 缺失或为 0",
| "error_code": "E_CORE_INPUT",
| "error_type": "CoreInputError",
| "recorded_at": "2026-08-25T19:56:53.844+08:00",
| "rollback_errors": [],
| "run_id": "38916536694945baac73c5b0bb33e7e7",
| "schema_version": 2,
| "status": "BLOCKED"
| },
| "v2_runtime_package": "v2_002317_SZ.failed-38916536694945baac73c5b0bb33e7e7",
| "v2_raw_artifact_hashes": [
| "35920b1b4861418cef690e33f188c3b2590201198e08c097486c2b2da739d205",
| "600b5d8415c752a33504840f2ac281452cb29ba7c00b6eefdd424aacca79b571",
| "7c6cf56d24adea9b2dffb71b389d47ed9fd299a48c6c0736276e65716fd5f1f3",
| "7f2bacafbdd37d525fb6b368bdf665d1b9b5555e853fe4fe3d0b5cf9661f36c7",
| "86bc0d4d3cf5a5131ae7b9e2bf6a9495c13e096c00945cb3d7069978451da5b4",
| "a02b976e06f4e4d6d4e1526a3085c830769a17fea2bbd665d08170014a1d11c0",
| "ad06602493401362ec94959c9a52177322faac647210fa73e5b9fb78679b63d4",
| "db04c62673f978ba495086e396c3a5abfe920c61b61bbf183255fa24c6644141",
| "e6e69df18c0ae1661313b128a5425cf9b9f16fcc7e5bd7e1c3fe0209cb7d3428",
| "e94514541e20151632eb7f8cbb826d9ae73f639fb33df7f8b1ff071ef67158c9"
| ],
| "market_contract": {
| "table": "trading_xuntou.cn_stock_kline_1d_front",
| "source": "xtquant",
| "source_batch_id": "FKL_20260825_161021_6bd1f63d_1d_20260825_00003",
| "updated_at": "2026-08-25 16:36:38",
| "trade_date": "2026-08-25"
| },
| "quote_raw_hash": "ad06602493401362ec94959c9a52177322faac647210fa73e5b9fb78679b63d4",
| "share_proof": {
| "shares": 849930477.0,
| "shares_fallback": false,
| "shares_fallback_source": "eastmoney.market:f84",
| "report_shares": 849930477.0,
| "share_unit_correction": null,
| "static_total_shares": 849930477.0,
| "match_report": true,
| "quote_market_cap": 21664727858.73,
| "price_times_shares": 21664727858.73,
| "gap_rate": 0.0
| },
| "industry_membership": {
| "industries": [
| "医药"
| ],
| "layers": [
| "reverse:医药、创新药与疫苗",
| "timeline"
| ],
| "research_name": "众生药业"
| },
| "bounded_gaps": [
| "V2 quote f124=0，端到端流程诚实阻断；正式估值用当前总股本/市值勾稽，股本历史日期无A1完全匹配时显式保留缺口。",
| "机构汇总缺逐家报告日期与明细，不把一致预期写成法定事实。"
| ],
| "checks": {
| "v1_qa": {
| "error_count": 0,
| "info_count": 0,
| "issues": [
| {
| "action": "拆解营运资本、资本开支与回款持续性。",
| "field": "metrics.annual_fcf",
| "issue_id": "QA-NEGATIVE-FCF",
| "message": "最近完整年度简化自由现金流为负。",
| "recalc_scope": "DCF 与现金流交叉验证",
| "severity": "WARNING"
| }
| ],
| "status": "PASS_WITH_WARNINGS",
| "warning_count": 1
| },
| "label": "偏贵",
| "base_low": 5.440500000000001,
| "base_high": 13.717500000000001,
| "optimistic_high": 26.502209999999998,
| "price": 25.49,
| "bubble_status": "泡沫-高"
| }
| }
|
|
